A growing body of evidence has proved that inhibition of neovascularization via suppressing HIF-1α/VEGF/VEGFR2 signaling pathway may delay tumor progression and perhaps even starve tumor cells to death [4]. The gene discussed is HIF1A; the disease is neoplasm.